Iratumumab (MDX-060), a human anti-CD30 IgG1kappa monoclonal antibody, inhibits the growth of CD30-expressing tumor cells and is utilized in the research of Hodgkins lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) [1].
CAS Number:
[640735-09-7]
* VAT and and shipping costs not included. Errors and price changes excepted